{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:48:06Z","timestamp":1787748486309,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872790"],"award-info":[{"award-number":["31872790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071113"],"award-info":[{"award-number":["32071113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600210"],"award-info":[{"award-number":["81600210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212059"],"award-info":[{"award-number":["7212059"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atherosclerotic plaque vulnerability and rupture increase the risk of acute coronary syndromes. Advanced lesion macrophage apoptosis plays important role in the rupture of atherosclerotic plaque, and endoplasmic reticulum stress (ERS) has been proved to be a key mechanism of macrophage apoptosis. Intermedin (IMD) is a regulator of ERS. Here, we investigated whether IMD enhances atherosclerotic plaque stability by inhibiting ERS-CHOP-mediated apoptosis and subsequent inflammasome in macrophages. We studied the effects of IMD on features of plaque vulnerability in hyperlipemia apolipoprotein E-deficient (ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>) mice. Six-week IMD<jats:sub>1-53<\/jats:sub>infusion significantly reduced atherosclerotic lesion size. Of note, IMD<jats:sub>1-53<\/jats:sub>lowered lesion macrophage content and necrotic core size and increased fibrous cap thickness and vascular smooth muscle cells (VSMCs) content thus reducing overall plaque vulnerability. Immunohistochemical analysis indicated that IMD<jats:sub>1-53<\/jats:sub>administration prevented ERS activation in aortic lesions of ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>mice, which was further confirmed in oxidized low-density lipoproteins (ox-LDL) induced macrophages. Similar to IMD, taurine (Tau), a non-selective ERS inhibitor significantly reduced atherosclerotic lesion size and plaque vulnerability. Moreover, C\/EBP-homologous protein (CHOP), a pro-apoptosis transcription factor involved in ERS, was significantly increased in advanced lesion macrophages, and deficiency of CHOP stabilized atherosclerotic plaques in AopE<jats:sup>\u2212\/\u2212<\/jats:sup>mice. IMD<jats:sub>1-53<\/jats:sub>decreased CHOP level and apoptosis in vivo and in macrophages treated with ox-LDL. In addition, IMD<jats:sub>1-53<\/jats:sub>infusion ameliorated NLRP3 inflammasome and subsequent proinflammatory cytokines in vivo and in vitro. IMD may attenuate the progression of atherosclerotic lesions and plaque vulnerability by inhibiting ERS-CHOP-mediated macrophage apoptosis, and subsequent NLRP3 triggered inflammation. The inhibitory effect of IMD on ERS-induced macrophages apoptosis was probably mediated by blocking CHOP activation.<\/jats:p>","DOI":"10.1038\/s41419-021-03712-w","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:58:59Z","timestamp":1620043139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Intermedin1-53 attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages"],"prefix":"10.1038","volume":"12","author":[{"given":"Jin-Ling","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo-Zhi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Shu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-0491","authenticated-orcid":false,"given":"Yong-Fen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1982-390X","authenticated-orcid":false,"given":"Wei-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"3712_CR1","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2119\/molmed.2015.00027","volume":"21","author":"M Le Borgne","year":"2015","unstructured":"Le Borgne, M., Caligiuri, G. & Nicoletti, A. Once upon a time: the adaptive immune response in atherosclerosis\u2013a fairy tale no more. Mol. Med. 21, S13\u2013S18 (2015).","journal-title":"Mol. Med."},{"key":"3712_CR2","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1111\/bph.13700","volume":"174","author":"AP Sage","year":"2017","unstructured":"Sage, A. P. & Mallat, Z. Readapting the adaptive immune response\u2014therapeutic strategies for atherosclerosis. Br. J. Pharm. 174, 3926\u20133939 (2017).","journal-title":"Br. J. Pharm."},{"key":"3712_CR3","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.117.030484","volume":"136","author":"GK Hansson","year":"2017","unstructured":"Hansson, G. K. Inflammation and atherosclerosis: the end of a controversy. Circulation 136, 1875\u20131877 (2017).","journal-title":"Circulation"},{"key":"3712_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1161\/01.ATV.17.10.1859","volume":"17","author":"RT Lee","year":"1997","unstructured":"Lee, R. T. & Libby, P. The unstable atheroma. Arterioscler Thromb. Vasc. Biol. 17, 1859\u20131867 (1997).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3712_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","volume":"34","author":"E Falk","year":"2013","unstructured":"Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V. & Virmani, R. Update on acute coronary syndromes: the pathologists\u2019 view. Eur. Heart J. 34, 719\u2013728 (2013).","journal-title":"Eur. Heart J."},{"key":"3712_CR6","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1161\/01.ATV.0000097783.01596.E2","volume":"23","author":"E Lutgens","year":"2003","unstructured":"Lutgens, E. et al. Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb. Vasc. Biol. 23, 2123\u20132130 (2003).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3712_CR7","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon, J. F., Otsuka, F., Virmani, R. & Falk, E. Mechanisms of plaque formation and rupture. Circ. Res. 114, 1852\u20131866 (2014).","journal-title":"Circ. Res."},{"key":"3712_CR8","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/eurheartj\/eht301","volume":"34","author":"S Yla-Herttuala","year":"2013","unstructured":"Yla-Herttuala, S. et al. Stabilization of atherosclerotic plaques: an update. Eur. Heart J. 34, 3251\u20133258 (2013).","journal-title":"Eur. Heart J."},{"key":"3712_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1089\/ars.2009.2469","volume":"11","author":"I Tabas","year":"2009","unstructured":"Tabas, I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid. Redox Signal 11, 2333\u20132339 (2009).","journal-title":"Antioxid. Redox Signal"},{"key":"3712_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.2174\/0929867322666150311150829","volume":"22","author":"L Cominacini","year":"2015","unstructured":"Cominacini, L. et al. The atherosclerotic plaque vulnerability: focus on the oxidative and endoplasmic reticulum stress in orchestrating the macrophage apoptosis in the formation of the necrotic core. Curr. Med Chem. 22, 1565\u20131572 (2015).","journal-title":"Curr. Med Chem."},{"key":"3712_CR11","first-page":"3462530","volume":"2019","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. ER stress activates the NLRP3 inflammasome: a novel mechanism of atherosclerosis. Oxid. Med. Cell Longev. 2019, 3462530 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"3712_CR12","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/cells9092067","volume":"9","author":"S Gonzalez-Ramos","year":"2020","unstructured":"Gonzalez-Ramos, S. et al. Deletion or inhibition of NOD1 favors plaque stability and attenuates atherothrombosis in advanced atherogenesis (dagger). Cells 9, 2067 (2020).","journal-title":"Cells"},{"key":"3712_CR13","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1253\/circj.CJ-16-0924","volume":"80","author":"MF Linton","year":"2016","unstructured":"Linton, M. F. et al. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ. J. 80, 2259\u20132268 (2016).","journal-title":"Circ. J."},{"key":"3712_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1139\/bcb-2019-0057","volume":"98","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells. Biochem. Cell Biol. 98, 120\u2013129 (2020).","journal-title":"Biochem. Cell Biol."},{"key":"3712_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/ijms17020193","volume":"17","author":"EA Ivanova","year":"2016","unstructured":"Ivanova, E. A. & Orekhov, A. N. The role of endoplasmic reticulum stress and unfolded protein response in atherosclerosis. Int. J. Mol. Sci. 17, 193 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"3712_CR16","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1096\/fj.201700012R","volume":"31","author":"I Grechowa","year":"2017","unstructured":"Grechowa, I., Horke, S., Wallrath, A., Vahl, C. F. & Dorweiler, B. Human neutrophil elastase induces endothelial cell apoptosis by activating the PERK-CHOP branch of the unfolded protein response. FASEB J. 31, 3868\u20133881 (2017).","journal-title":"FASEB J."},{"key":"3712_CR17","doi-asserted-by":"crossref","unstructured":"Di Pasquale, E. & Condorelli, G. Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis. EMBO Mol. Med. 11, e10360 (2019).","DOI":"10.15252\/emmm.201910360"},{"key":"3712_CR18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.305602","volume":"116","author":"AX Zhou","year":"2015","unstructured":"Zhou, A. X. et al. C\/EBP-homologous protein (CHOP) in vascular smooth muscle cells regulates their proliferation in aortic explants and atherosclerotic lesions. Circ. Res. 116, 1736\u20131743 (2015).","journal-title":"Circ. Res."},{"key":"3712_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ncb1035","volume":"5","author":"B Feng","year":"2003","unstructured":"Feng, B. et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5, 781\u2013792 (2003).","journal-title":"Nat. Cell Biol."},{"key":"3712_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/CIRCULATIONAHA.106.682054","volume":"116","author":"M Myoishi","year":"2007","unstructured":"Myoishi, M. et al. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation 116, 1226\u20131233 (2007).","journal-title":"Circulation"},{"key":"3712_CR21","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1161\/ATVBAHA.110.206094","volume":"30","author":"H Tsukano","year":"2010","unstructured":"Tsukano, H. et al. The endoplasmic reticulum stress-C\/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb. Vasc. Biol. 30, 1925\u20131932 (2010).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3712_CR22","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.107.728378","volume":"116","author":"JG Dickhout","year":"2007","unstructured":"Dickhout, J. G., Colgan, S. M., Lhotak, S. & Austin, R. C. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome: A balancing act between plaque stability and rupture. Circulation 116, 1214\u20131216 (2007).","journal-title":"Circulation"},{"key":"3712_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11427-014-4701-7","volume":"57","author":"X Ni","year":"2014","unstructured":"Ni, X., Zhang, J., Tang, C. & Qi, Y. Intermedin\/adrenomedullin2: an autocrine\/paracrine factor in vascular homeostasis and disease. Sci. China Life Sci. 57, 781\u2013789 (2014).","journal-title":"Sci. China Life Sci."},{"key":"3712_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1476-5381.2011.01530.x","volume":"166","author":"Y Hong","year":"2012","unstructured":"Hong, Y., Hay, D. L., Quirion, R. & Poyner, D. R. The pharmacology of adrenomedullin 2\/intermedin. Br. J. Pharm. 166, 110\u2013120 (2012).","journal-title":"Br. J. Pharm."},{"key":"3712_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/cvr\/cvt254","volume":"101","author":"X Dai","year":"2014","unstructured":"Dai, X. et al. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA. Cardiovasc Res. 101, 297\u2013305 (2014).","journal-title":"Cardiovasc Res."},{"key":"3712_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.yjmcc.2012.07.006","volume":"53","author":"X Dai","year":"2012","unstructured":"Dai, X. et al. Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice. J. Mol. Cell Cardiol. 53, 509\u2013520 (2012).","journal-title":"J. Mol. Cell Cardiol."},{"key":"3712_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12020-018-1657-6","volume":"62","author":"X Ni","year":"2018","unstructured":"Ni, X. et al. Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO Mice. Endocrine 62, 90\u2013106 (2018).","journal-title":"Endocrine"},{"key":"3712_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.peptides.2011.12.016","volume":"33","author":"L Zhao","year":"2012","unstructured":"Zhao, L. et al. Extracellular signal-regulated kinase 1\/2 activation is involved in intermedin1-53 attenuating myocardial oxidative stress injury induced by ischemia\/reperfusion. Peptides 33, 329\u2013335 (2012).","journal-title":"Peptides"},{"key":"3712_CR29","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1097\/HJH.0000000000000597","volume":"33","author":"W Lu","year":"2015","unstructured":"Lu, W. et al. Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase. J. Hypertens. 33, 1676\u20131687 (2015).","journal-title":"J. Hypertens."},{"key":"3712_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCRESAHA.115.306233","volume":"117","author":"L Dong","year":"2015","unstructured":"Dong, L. et al. TRAF6-mediated SM22alpha K21 ubiquitination promotes G6PD activation and NADPH production, contributing to GSH homeostasis and VSMC survival in vitro and in vivo. Circ. Res. 117, 684\u2013694 (2015).","journal-title":"Circ. Res."},{"key":"3712_CR31","doi-asserted-by":"publisher","first-page":"S382","DOI":"10.1194\/jlr.R800032-JLR200","volume":"50","author":"T Seimon","year":"2009","unstructured":"Seimon, T. & Tabas, I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50, S382\u2013S387 (2009). Suppl.","journal-title":"J. Lipid Res."},{"key":"3712_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1074248419885633","volume":"25","author":"J Ren","year":"2020","unstructured":"Ren, J. et al. Intermedin1-53 ameliorates homocysteine-promoted atherosclerotic calcification by inhibiting endoplasmic reticulum stress. J. Cardiovasc Pharm. Ther. 25, 251\u2013264 (2020).","journal-title":"J. Cardiovasc Pharm. Ther."},{"key":"3712_CR33","doi-asserted-by":"publisher","first-page":"170131","DOI":"10.1016\/j.peptides.2019.170131","volume":"121","author":"C Xue","year":"2019","unstructured":"Xue, C. et al. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress. Peptides 121, 170131 (2019).","journal-title":"Peptides"},{"key":"3712_CR34","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.5551\/jat.34082","volume":"23","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Intermedin1-53 protects against myocardial fibrosis by inhibiting endoplasmic reticulum stress and inflammation induced by homocysteine in apolipoprotein E-deficient mice. J. Atheroscler. Thromb. 23, 1294\u20131306 (2016).","journal-title":"J. Atheroscler. Thromb."},{"key":"3712_CR35","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/ATVBAHA.116.307825","volume":"36","author":"W Lu","year":"2016","unstructured":"Lu, W. et al. Intermedin1-53 attenuates abdominal aortic aneurysm by inhibiting oxidative stress. Arterioscler Thromb. Vasc. Biol. 36, 2176\u20132190 (2016).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3712_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12031-020-01697-3","volume":"71","author":"X Guo","year":"2021","unstructured":"Guo, X., Yuan, J., Li, M., Wang, M. & Lv, P. Neuroprotection of intermedin against cerebral ischemia\/reperfusion injury through cerebral microcirculation improvement and apoptosis inhibition. J. Mol. Neurosci. 71, 767\u2013777 (2021).","journal-title":"J. Mol. Neurosci."},{"key":"3712_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000107513","volume":"20","author":"D Bell","year":"2007","unstructured":"Bell, D., Zhao, Y., McCoy, F. P., Devine, A. B. & McDermott, B. J. Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency. Cell Physiol. Biochem. 20, 269\u2013282 (2007).","journal-title":"Cell Physiol. Biochem."},{"key":"3712_CR38","doi-asserted-by":"publisher","first-page":"106951","DOI":"10.1016\/j.intimp.2020.106951","volume":"88","author":"S Fan","year":"2020","unstructured":"Fan, S. et al. Intermedin alleviates the inflammatory response and stabilizes the endothelial barrier in LPS-induced ARDS through the PI3K\/Akt\/eNOS signaling pathway. Int. Immunopharmacol. 88, 106951 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"3712_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05062-2","volume":"9","author":"F Xiao","year":"2018","unstructured":"Xiao, F. et al. Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses. Nat. Commun. 9, 2644 (2018).","journal-title":"Nat. Commun."},{"key":"3712_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.peptides.2012.07.011","volume":"37","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. Intermedin ameliorates atherosclerosis in ApoE null mice by modifying lipid profiles. Peptides 37, 189\u2013193 (2012).","journal-title":"Peptides"},{"key":"3712_CR41","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.4238\/2014.October.20.7","volume":"13","author":"S Yang","year":"2014","unstructured":"Yang, S., Liu, J. & Li, C. Intermedin protects against myocardial ischemia-reperfusion injury in hyperlipidemia rats. Genet Mol. Res. 13, 8309\u20138319 (2014).","journal-title":"Genet Mol. Res."},{"key":"3712_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1475-2840-12-91","volume":"12","author":"H Li","year":"2013","unstructured":"Li, H. et al. Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats. Cardiovasc Diabetol. 12, 91 (2013).","journal-title":"Cardiovasc Diabetol."},{"key":"3712_CR43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/1535370213502619","volume":"238","author":"J Chang","year":"2013","unstructured":"Chang, J. et al. Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate\/protein kinase A pathway. Exp. Biol. Med. 238, 1136\u20131146 (2013).","journal-title":"Exp. Biol. Med."},{"key":"3712_CR44","doi-asserted-by":"publisher","first-page":"e64757","DOI":"10.1371\/journal.pone.0064757","volume":"8","author":"H Chen","year":"2013","unstructured":"Chen, H. et al. Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy. PLoS ONE 8, e64757 (2013).","journal-title":"PLoS ONE"},{"key":"3712_CR45","doi-asserted-by":"crossref","first-page":"e13253","DOI":"10.1111\/eci.13253","volume":"50","author":"A Bonaventura","year":"2020","unstructured":"Bonaventura, A., Liberale, L., Carbone, F., Vecchie, A. & Montecucco, F. Plaque vulnerability and adverse outcomes: The long road to fight atherosclerosis. Eur. J. Clin. Investig. 50, e13253 (2020).","journal-title":"Eur. J. Clin. Investig."},{"key":"3712_CR46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cmet.2009.03.003","volume":"9","author":"E Thorp","year":"2009","unstructured":"Thorp, E. et al. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-\/- and Ldlr-\/- mice lacking CHOP. Cell Metab. 9, 474\u2013481 (2009).","journal-title":"Cell Metab."},{"key":"3712_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.388","volume":"7","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Adiponectin reduces ER stress-induced apoptosis through PPARalpha transcriptional regulation of ATF2 in mouse adipose. Cell Death Dis. 7, e2487 (2016).","journal-title":"Cell Death Dis."},{"key":"3712_CR48","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/jcp.25930","volume":"233","author":"Z Hoseini","year":"2018","unstructured":"Hoseini, Z. et al. NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J. Cell Physiol. 233, 2116\u20132132 (2018).","journal-title":"J. Cell Physiol."},{"key":"3712_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.10.027","volume":"267","author":"M Baldrighi","year":"2017","unstructured":"Baldrighi, M., Mallat, Z. & Li, X. NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis 267, 127\u2013138 (2017).","journal-title":"Atherosclerosis"},{"key":"3712_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.117.033098","volume":"138","author":"N Paulin","year":"2018","unstructured":"Paulin, N. et al. Double-strand DNA sensing aim2 inflammasome regulates atherosclerotic plaque vulnerability. Circulation 138, 321\u2013323 (2018).","journal-title":"Circulation"},{"key":"3712_CR51","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10753-020-01290-1","volume":"43","author":"A Liaqat","year":"2020","unstructured":"Liaqat, A., Asad, M., Shoukat, F. & Khan, A. U. A spotlight on the underlying activation mechanisms of the NLRP3 inflammasome and its role in atherosclerosis: a review. Inflammation 43, 2011\u20132020 (2020).","journal-title":"Inflammation"},{"key":"3712_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","volume":"73","author":"N Parsamanesh","year":"2019","unstructured":"Parsamanesh, N. et al. NLRP3 inflammasome as a treatment target in atherosclerosis: a focus on statin therapy. Int. Immunopharmacol. 73, 146\u2013155 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"3712_CR53","doi-asserted-by":"publisher","first-page":"10845","DOI":"10.1073\/pnas.191207498","volume":"98","author":"S Oyadomari","year":"2001","unstructured":"Oyadomari, S. et al. Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc. Natl Acad. Sci. USA 98, 10845\u201310850 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3712_CR54","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1084\/jem.20131281","volume":"211","author":"Y Sui","year":"2014","unstructured":"Sui, Y. et al. IKKbeta links vascular inflammation to obesity and atherosclerosis. J. Exp. Med. 211, 869\u2013886 (2014).","journal-title":"J. Exp. Med."},{"key":"3712_CR55","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1194\/jlr.M014092","volume":"52","author":"C Zhou","year":"2011","unstructured":"Zhou, C., Pridgen, B., King, N., Xu, J. & Breslow, J. L. Hyperglycemic Ins2AkitaLdlr-\/- mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease. J. Lipid Res. 52, 1483\u20131493 (2011).","journal-title":"J. Lipid Res."},{"key":"3712_CR56","doi-asserted-by":"publisher","first-page":"e000492","DOI":"10.1161\/JAHA.113.000492","volume":"3","author":"Y Sui","year":"2014","unstructured":"Sui, Y. et al. Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice. J. Am. Heart Assoc. 3, e000492 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"3712_CR57","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/ATVBAHA.118.311059","volume":"38","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Myeloid beta-Catenin deficiency exacerbates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb. Vasc. Biol. 38, 1468\u20131478 (2018).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3712_CR58","doi-asserted-by":"crossref","first-page":"e012009","DOI":"10.1161\/JAHA.119.012009","volume":"8","author":"W Lu","year":"2019","unstructured":"Lu, W., Park, S. H., Meng, Z., Wang, F. & Zhou, C. Deficiency of adipocyte IKKbeta affects atherosclerotic plaque vulnerability in obese LDLR deficient mice. J. Am. Heart Assoc. 8, e012009 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"3712_CR59","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1161\/ATVBAHA.112.254573","volume":"32","author":"SH Park","year":"2012","unstructured":"Park, S. H. et al. Myeloid-specific IkappaB kinase beta deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb. Vasc. Biol. 32, 2869\u20132876 (2012).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"3712_CR60","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbrc.2017.05.159","volume":"489","author":"M Dong","year":"2017","unstructured":"Dong, M., Zhou, C., Ji, L., Pan, B. & Zheng, L. AG1296 enhances plaque stability via inhibiting inflammatory responses and decreasing MMP-2 and MMP-9 expression in ApoE-\/- mice. Biochem Biophys. Res. Commun. 489, 426\u2013431 (2017).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"3712_CR61","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","volume":"63","author":"S Leng","year":"2008","unstructured":"Leng, S. et al. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A Biol. Sci. Med. Sci. 63, 879\u2013884 (2008).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03712-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T05:29:48Z","timestamp":1698989388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03712-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["3712"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03712-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal care and experimental protocols complied with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, 8th Edition, 2011) and were approved by the Animal Care Committee of Peking University Health Science Center (Beijing).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"436"}}